Titan Pharmaceuticals, Inc. (TTNP)
- Previous Close
4.6000 - Open
4.8000 - Bid 4.4400 x 100
- Ask 4.9800 x 100
- Day's Range
4.6200 - 4.8560 - 52 Week Range
3.0300 - 14.8000 - Volume
39,351 - Avg. Volume
38,204 - Market Cap (intraday)
4.352M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-5.2300 - Earnings Date May 15, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.
www.titanpharm.comRecent News: TTNP
View More
Performance Overview: TTNP
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TTNP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TTNP
View MoreValuation Measures
Market Cap
4.35M
Enterprise Value
-1.77M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.78
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-51.74%
Return on Equity (ttm)
-103.63%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.71M
Diluted EPS (ttm)
-5.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
2.83M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.07M